Publicacións nas que colabora con Alvaro Ruibal Morell (22)

2024

  1. Partial volume correction in longitudinal tau PET studies: is it really needed?

    NeuroImage, Vol. 289

2021

  1. Feasibility of Longitudinal Brain PET with Real-Time Arterial Input Function in Rats

    Molecular Imaging and Biology, Vol. 23, Núm. 3, pp. 350-360

  2. Quantification of internal dosimetry in PET patients II: Individualized Monte Carlo-based dosimetry for [18F]fluorocholine PET

    Medical Physics, Vol. 48, Núm. 9, pp. 5448-5458

2020

  1. -FMISO PET/MRI Imaging Shows Ischemic Tissue around Hematoma in Intracerebral Hemorrhage

    Molecular Pharmaceutics, Vol. 17, Núm. 12, pp. 4667-4675

  2. 3D printed tacrolimus rectal formulations ameliorate colitis in an experimental animal model of inflammatory bowel disease

    Biomedicines, Vol. 8, Núm. 12, pp. 1-19

  3. PET study of ocular and blood pharmacokinetics of intravitreal bevacizumab and aflibercept in rats

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 154, pp. 330-337

  4. Quantification of internal dosimetry in PET patients: individualized Monte Carlo vs generic phantom-based calculations

    Medical Physics, Vol. 47, Núm. 9, pp. 4574-4588

2019

  1. Evaluation of the therapeutic activity of melatonin and resveratrol in Inflammatory Bowel Disease: A longitudinal PET/CT study in an animal model

    International Journal of Pharmaceutics, Vol. 572

  2. Ocular bio distribution studies using molecular imaging

    Pharmaceutics, Vol. 11, Núm. 5

  3. Prediction of Alzheimer's disease dementia with MRI beyond the short-term: Implications for the design of predictive models

    NeuroImage: Clinical, Vol. 23

  4. Staging the cognitive continuum in prodromal Alzheimer's disease with episodic memory

    Neurobiology of Aging, Vol. 84, pp. 1-8

2018

  1. Longitudinal PET/CT evaluation of TNBS-induced inflammatory bowel disease rat model

    International Journal of Pharmaceutics, Vol. 549, Núm. 1-2, pp. 335-342

  2. Preclinical characterization and clinical evaluation of tacrolimus eye drops

    European Journal of Pharmaceutical Sciences, Vol. 120, pp. 152-161

  3. Texture analysis of high-resolution dedicated breast 18 F-FDG PET images correlates with immunohistochemical factors and subtype of breast cancer

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, Núm. 2, pp. 196-206

2017

  1. Impact of muscular uptake and statistical noise on tumor quantification based on simulated FDG-PET studies

    Radiation Physics and Chemistry, Vol. 131, pp. 28-34

  2. In vivo eye surface residence determination by high-resolution scintigraphy of a novel ion-sensitive hydrogel based on gellan gum and kappa-carrageenan

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 114, pp. 317-323

  3. Positron emission tomography for the development and characterization of corneal permanence of ophthalmic pharmaceutical formulations

    Investigative Ophthalmology and Visual Science, Vol. 58, Núm. 2, pp. 772-780

  4. Preclinical PET study of intravitreal injections

    Investigative Ophthalmology and Visual Science, Vol. 58, Núm. 7, pp. 2843-2851

2016

  1. Evaluation and optimization of occupational eye lens dosimetry during positron emission tomography (PET) procedures

    Journal of Radiological Protection, Vol. 36, Núm. 2, pp. 299-308

  2. Impact and correction of the bladder uptake on 18F-FCH PET quantification: A simulation study using the XCAT2 phantom

    Physics in Medicine and Biology, Vol. 61, Núm. 2, pp. 758-773